Found 10 matching trials
Understanding Hemophilia A and B Drug Dosage Administration Patterns N/A Study Design
A prospective observational, cross-sectional epidemiological ...
Show More Location
University of Florida College of Medicine
Learn More & Join Trial
A Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B in France N/A Alprolix (rFIXFc) is a recombinant extended half-life coagulation factor pr...
Show More Location
Swedish Orphan Biovitrum Research Site (CHU de Bordeaux)
Learn More & Join Trial
An International Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B N/A Alprolix (rFIXFc) is a recombinant extended half-life coagulation factor pr...
Show More Location
Swedish Orphan Biovitrum Research Site
Learn More & Join Trial
Study of Surgical Practices in Patients With Haemophilia A or B Treated With an Extended Half-life Recombinant Factor VIII-Fc or IX-Fc (ELOCTA®, ALPROLIX®) N/A Haemophilia A and haemophilia B are inherited bleeding disorders resulting ...
Show More Location
Centre de Référence en Hémophilie, hôpityal Louis Pradel, GHE- Hospices Civils de Lyon
Learn More & Join Trial
Joint Health Study N/A This is a prospective, non-randomized, controlled study to examine whether ...
Show More Location
Orthopaedic Institute for Children at University of California Los Angeles
Learn More & Join Trial
A Study to Evaluate the Real-world Usage and Effectiveness of Elocta and Alprolix in Patients With Haemophilia A or B N/A Elocta (rFVIIIFc) and Alprolix (rFIXFc) are recombinant extended half-life ...
Show More Location
Swedish Orphan Biovitrum Reserach site
Learn More & Join Trial
Extended Half Life Factor (EHF) Products For Heavy Menstrual Bleeding in Hemophilia Carriers EARLY_PHASE1 The purpose of this feasibility study is to find out if two clotting factor...
Show More Location
Emory University Hospital Clinical Research Network
Learn More & Join Trial
Association of Prophylactic Treatment With Treatment Burden and Psychosocial Variables in Patients With Hemophilia N/A Introduction: Hemophilia is a congenital coagulopathy characterised by recu...
Show More Location
Universidad de Oviedo
Learn More & Join Trial
UK - EHL Outcomes Registry N/A Severe haemophilia A and B (SHA, SHB) are inherited bleeding disorders affe...
Show More Location
Basingstoke and North Hampshire Hospital
Learn More & Join Trial
Dosage and PD Study of Eftrenonacog-alfa N/A The purpose of this study is to evaluate the performance of different metho...
Show More Location
Service d'hématologie biologique - Hôpital Cochin
Learn More & Join Trial